Denys H, Martinez-Mena CL, Martens MT, D'Hondt RG, et al. Safety and tolerability of subcutaneous trastuzumab at home administration,
results of the phase IIIb open-label BELIS study in HER2-positive early breast
cancer. Breast Cancer Res Treat 2020 Apr 2. pii: 10.1007/s10549-020-05604.
PMID: 32240454